AIQ Solutions has a software-as-a-service platform that helps improve the treatment of complex diseases, such as metastatic cancer, leading to better patient outcomes and reduced treatment costs. The software uses artificial intelligence and other advanced analytics to automatically detect disease from PET/CT scans and precisely measure response to treatment for each individual lesion, which is not possible with existing technology.
AIQ Solutions Hits On $3.2M to Pinpoint Drug-Resistant Tumors
Many companies developing artificial intelligence software for healthcare are trying to improve doctors’ ability to diagnose disease. Fewer emerging healthcare AI businesses are focused on what happens after a diagnosis, aiming to figure out how treatments are working.